Maternal plasma soluble fms-like tyrosine kinase-1 and placental growth factor levels as biochemical markers of gestational hypertension for Malaysian mothers

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 5, 2009, Pages 855-863

  Nadarajah, Vishna D ^a   Min, Richard G L Y ^a   Judson, John P ^a   Jegasothy, Ravindran ^b   Ling, Elena H P ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b Hospital Tuanku Jaafar   (Malaysia)

Author keywords

Gestational hypertension (GH); Normotensive Malaysian mothers; Placental growth factor (PlGF); Pre eclampsia; Soluble Fms like tyrosine kinase 1 (sFlt 1)

Indexed keywords

BIOCHEMICAL MARKER; PLACENTAL GROWTH FACTOR; PROTEIN KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALAYSIA; MATERNAL HYPERTENSION; MATERNAL PLASMA; PREGNANCY; PREGNANCY DIABETES MELLITUS; RANK SUM TEST; VAGINAL DELIVERY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MALAYSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 70350440295     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2009.01037.x     Document Type: Article

References (20)

1. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 2008 78 : 93 100.
2. Hertig A, Berkane N, Lefevre G et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004 50 : 1702 1703.
3. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol 2005 122 : 33 39.
4. Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 2006 194 : 551 556.
5. Stepan H, Faber R, Dornhöfer N, Huppertz B, Robitzki A, Walther T. New insights into the biology of preeclampsia. Biol Reprod 2006 74 : 772 776.
6. Foyouzi N, Norwitz ER, Tsen LC, Buhimschi CS, Buhimschi IA. Placental growth factor in the cerebrospinal fluid of women with preeclampsia. Int J Gynecol Obstet 2006 92 : 32 37.
7. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Am Soc Clin Invest 2003 111 : 649 658.
8. Levine RJ, Maynard SE, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004 350 : 672 683.
9. Krauss T, Pauer HU, Augustin HG. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004 23 : 101 111.
10. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: The 'chicken-and-egg' question. Endocrinology 2004 145 : 4835 4837.
11. Rao AK, Daniels K, El-Sayed YY, Moshesh MK, Caughey AB. Perinatal outcomes among Asian American and Pacific Islander women. Am J Obstet Gynecol 2006 195 : 834 838.
12. Hirashima C, Ohkuchi A, Arai F et al. Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res 2005 28 : 727 732.
13. Dean AG, Sullivan KM, Soe MM. Openepi: Open Source Epidemiologic Statistics for Public Health. Updated (8 June 2007). [Cited 3 July 2007.] Available from URL: http://www.OpenEpi.com.
14. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 2005 48 : 372 386.
15. Ong CY, Lao TT, Spencer K, Nicolaides KH. Maternal serum level of placental growth factor in diabetic pregnancies. J Reprod Med 2004 49 : 477 480.
16. Zhao B, Cai J, Boulton M. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2. Microvasc Res 2004 68 : 239 246.
17. Miura H, Wachtel RE, Loberiza FR et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles - Reduced activity of ATP-sensitive potassium channels. Circ Res 2003 92 : 151.
18. Marzio DD, Mohn A, Martino MD, Chiarelli F. Macroangiopathy in adults and children with diabetes: Risk factors (Part 2). Horm Metab Res 2006 38 : 706 720.
19. Levine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006 355 : 992 1005.
20. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003 188 : 177 182.